Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.82, $0.10 better than the analyst estimate of $2.72. Revenue for the quarter came in at $22.45 billion versus the consensus estimate of $22.34 billion.

GUIDANCE:

Johnson & Johnson sees FY2024 EPS of $10.05, versus the consensus of $10.01.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.